Lantheus Holdings (FRA:0L8) Total Stockholders Equity : €870 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Lantheus Holdings Total Stockholders Equity?

Lantheus Holdings's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €870 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Lantheus Holdings's Book Value per Share for the quarter that ended in Mar. 2024 was €12.55. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Lantheus Holdings's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.65.

Lantheus Holdings Total Stockholders Equity Historical Data

The historical data trend for Lantheus Holdings's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lantheus Holdings Total Stockholders Equity Chart

Lantheus Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

103.14

422.68

411.03

422.11

748.17

Lantheus Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															416.11	510.09	654.74	748.17	869.90

Lantheus Holdings (FRA:0L8) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Lantheus Holdings's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(869.897	-	0)	/	69.296
	=	12.55

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Lantheus Holdings's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.675	+	567.263)	/	869.897
	=	0.65

Lantheus Holdings Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Lantheus Holdings's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Lantheus Holdings (FRA:0L8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lantheus Holdings Inc (FRA:0L8) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

LNTH:USA 0L8:Germany

Address

201 Burlington Road, South Building, Bedford, MA, USA, 01730

Website

https://www.lantheus.com

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Lantheus Holdings (FRA:0L8) Headlines

No Headlines